THU0106 Rituximab after first anti-TNF failure is more efficient with high impact in reducing time and costs to achieve superior rates of low disease activity and remission

Abstract

BackgroundSignificant steps were done in creating new medications for treatment of rheumatoid arthritis (RA). As RA seriously affects the patients’ quality of life, the effectiveness of selected approaches is a...